LQDA Liquidia Technologies Inc

$22.86

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/6/2025

About Liquidia Technologies Inc

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and markets various products for the unmet needs of patients in the United States. The company is headquartered in Morrisville, North Carolina.

Website: https://www.liquidia.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1819576
Address
P.O. BOX 110085, RESEARCH TRIANGLE PARK, NC, US
Valuation
Market Cap
$1.17B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
15.14
Performance
EPS
$-1.66
Dividend Yield
—
Profit Margin
0.00%
ROE
-209.40%
Technicals
50D MA
$14.84
200D MA
$12.18
52W High
$16.81
52W Low
$8.26
Fundamentals
Shares Outstanding
85M
Target Price
$26.78
Beta
0.22

LQDA EPS Estimates vs Actual

● Estimated
● Actual

LQDA News & Sentiment

Oct 01, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Is IPF the Next Big Market Opportunity for United Therapeutics?
UTHR reports strong TETON-2 results for Tyvaso in IPF, showing lung function gains and eyeing a major new market.
Sep 29, 2025 • Benzinga NEUTRAL
Liquidia to Present Clinical Data from ASCENT Trial at the CHEST 2025 Annual Meeting - Liquidia ( NASDAQ:LQDA )
MORRISVILLE, N.C., Sept. 29, 2025 ( GLOBE NEWSWIRE ) -- Liquidia Corporation ( NASDAQ: LQDA ) , a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, announced today the company will present two oral presentations at the CHEST 2025 annual ...
Sep 11, 2025 • Benzinga SOMEWHAT-BULLISH
Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association ( PHPN ) Symposium - Liquidia ( NASDAQ:LQDA )
MORRISVILLE, N.C., Sept. 11, 2025 ( GLOBE NEWSWIRE ) -- Liquidia Corporation LQDA, a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that the company will present four posters at the Pulmonary Hypertension Professional ...
Sep 11, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association ( PHPN ) Symposium
MORRISVILLE, N.C., Sept. 11, 2025 ( GLOBE NEWSWIRE ) -- Liquidia Corporation ( NASDAQ: LQDA ) , a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that the company will present four posters at the Pulmonary Hypertension ...
Sep 03, 2025 • Zacks Commentary SOMEWHAT-BULLISH
UTHR Stock Hits Record High on Tyvaso Meeting IPF Study Goals
United Therapeutics hit a record high after its Tyvaso study in idiopathic pulmonary fibrosis met key goals and showed broad patient benefits.
Sep 02, 2025 • Benzinga SOMEWHAT-BULLISH
Liquidia Unusual Options Activity - Liquidia ( NASDAQ:LQDA )
High-rolling investors have positioned themselves bullish on Liquidia LQDA, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data.
Sentiment Snapshot

Average Sentiment Score:

0.144
50 articles with scored sentiment

Overall Sentiment:

Neutral

LQDA Reported Earnings

Mar 11, 2025
Dec 31, 2024 (Pre market)
-0.06 Surprise
  • Reported EPS: $-0.45
  • Estimate: $-0.40
  • Whisper: —
  • Surprise %: -13.9%
Nov 05, 2024
Sep 30, 2024 (Pre market)
-0.02 Surprise
  • Reported EPS: $-0.39
  • Estimate: $-0.37
  • Whisper: —
  • Surprise %: -4.8%
Aug 07, 2024
Jun 30, 2024 (Pre market)
-0.03 Surprise
  • Reported EPS: $-0.37
  • Estimate: $-0.34
  • Whisper: —
  • Surprise %: -8.8%
May 13, 2024
Mar 31, 2024 (Post market)
-0.22 Surprise
  • Reported EPS: $-0.54
  • Estimate: $-0.32
  • Whisper: —
  • Surprise %: -68.8%
Mar 13, 2024
Dec 31, 2023 (Pre market)
-0.18 Surprise
  • Reported EPS: $-0.42
  • Estimate: $-0.24
  • Whisper: —
  • Surprise %: -75.0%
Nov 07, 2023
Sep 30, 2023 (Pre market)
-0.03 Surprise
  • Reported EPS: $-0.24
  • Estimate: $-0.21
  • Whisper: —
  • Surprise %: -14.3%
Aug 10, 2023
Jun 30, 2023 (Pre market)
-0.2 Surprise
  • Reported EPS: $-0.36
  • Estimate: $-0.16
  • Whisper: —
  • Surprise %: -125.0%
May 04, 2023
Mar 31, 2023 (Pre market)
-0.02 Surprise
  • Reported EPS: $-0.18
  • Estimate: $-0.16
  • Whisper: —
  • Surprise %: -12.5%
Mar 16, 2023
Dec 31, 2022 (Pre market)
0.06 Surprise
  • Reported EPS: $-0.09
  • Estimate: $-0.15
  • Whisper: —
  • Surprise %: 40.0%

Financials